APA (7th ed.) Citation

DR, A., & MM, T. (2024). Perioperative Implications of the 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy. Journal of cardiothoracic and vascular anesthesia, 38(11), 2510. https://doi.org/10.1053/j.jvca.2024.07.039

Chicago Style (17th ed.) Citation

DR, Addis, and Townsley MM. "Perioperative Implications of the 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy." Journal of Cardiothoracic and Vascular Anesthesia 38, no. 11 (2024): 2510. https://doi.org/10.1053/j.jvca.2024.07.039.

MLA (9th ed.) Citation

DR, Addis, and Townsley MM. "Perioperative Implications of the 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy." Journal of Cardiothoracic and Vascular Anesthesia, vol. 38, no. 11, 2024, p. 2510, https://doi.org/10.1053/j.jvca.2024.07.039.